SciCombinator

Discover the most talked about and latest scientific content & concepts.

C Slack, N Alic, A Foley, M Cabecinha, MP Hoddinott and L Partridge
Abstract
Identifying the molecular mechanisms that underlie aging and their pharmacological manipulation are key aims for improving lifelong human health. Here, we identify a critical role for Ras-Erk-ETS signaling in aging in Drosophila. We show that inhibition of Ras is sufficient for lifespan extension downstream of reduced insulin/IGF-1 (IIS) signaling. Moreover, direct reduction of Ras or Erk activity leads to increased lifespan. We identify the E-twenty six (ETS) transcriptional repressor, Anterior open (Aop), as central to lifespan extension caused by reduced IIS or Ras attenuation. Importantly, we demonstrate that adult-onset administration of the drug trametinib, a highly specific inhibitor of Ras-Erk-ETS signaling, can extend lifespan. This discovery of the Ras-Erk-ETS pathway as a pharmacological target for animal aging, together with the high degree of evolutionary conservation of the pathway, suggests that inhibition of Ras-Erk-ETS signaling may provide an effective target for anti-aging interventions in mammals. VIDEO ABSTRACT.
Tweets*
102
Facebook likes*
9
Reddit*
3
News coverage*
3
Blogs*
3
SC clicks
0
Concepts
Medicine, Maximum life span, Senescence, Aging, Enzyme inhibitor, Life expectancy, Gene expression, Gerontology
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com